This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It’s time for us to get the annual update on health consumers from the multi-faceted team who curated the Global Wellness Summit’s annual report on The Future of Wellness 2023 Trends. And one trend deals with wellness + governments: the case for coming together, which I’m keen on with my lens on health citizenship.
Whether they are digital health, medical device, biotech, or pharma companies, healthtech has costly and inefficient sales processes that often stem from a lack of foundational data & insights to reach the right target markets efficiently and effectively. physicians, physician groups, hospitals, health systems, etc).
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. What are the biggest trends likely to affect healthcare technology multiples in 2025? 21st Century Cures Act) accelerates this trend. This is down from 6.5x
In my world view, this constitutes a trend, particularly since I haven’t been asked to speak on this topic repeatedly before. […]. In the last month I have spoken at an event about digital therapeutics and been invited to speak at 5 more unrelated events on the same topic (note: I am not doing them all).
Biotech is roughly tied for second place with consumer health, dropping also by 7 points. There’s another piece of math worth doing here: a chasm between biotech and pharma of 17 percentage points worth of trust — that is the difference between the 55% of American trusting biotech versus 38% trusting pharma.
This makes it easier than ever to establish a baseline, spot trends, and stay on top of wellness. Sanguina is a digital health and biotech company focused on advancing accessible digital and at-home health platforms. Existing AnemoCheck Mobile users will automatically begin transitioning to Ruby when the app updates on April 1, 2025.
These developments underscore the ongoing challenges and transformations in both the energy and biotechnology sectors, reflecting broader trends towards sustainability and financial stability. The restructuring aims to save around $35 million annually, despite incurring one-time costs of $12 million.
Meanwhile, innovations like Hera Biotech’s non-invasive test and Ziwig Biotech’s saliva test offer hope for a quicker diagnosis. The drug, dichloroacetate (DCA), reduces high levels of lactate, offering relief to patients. With larger trials underway, the drug could hit the market in 5-7 years.
A comprehensive and insightful report analyzing these transformative trends has been added to our industry-leading research publication collections. The Theranos Legacy 5 Market Trends 5.1 Biohacking trend supports self-testing. ADT Biotech 7.5 Mesa Biotech (Thermo Fisher) 7.42 Central Lab 4.3.4 Rapid Result 5.1.4
While giants like UnitedHealth or biotech stars like Vertex Pharmaceuticals often dominate headlines, Doximitys niche focus and execution have propelled it ahead. Doximity is well-positioned to benefit from this trend. Comparatively, the healthcare sector has lagged in recent years, but 2025 is showing signs of a turnaround.
Players Include 1DropDiagnostics, Abbott Laboratories, Ador Diagnostics, ADT Biotech and Akonni Biosystems DUBLIN–(BUSINESS WIRE)–The “OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Industry Structure 5 Market Trends 5.1 Industry Participants 4.2
As our ability to utilize data to demonstrate positive clinical outcomes continues to be enhanced through technology, healthcare and biotech companies are under increasing pressure to demonstrate positive clinical outcomes and patient benefits from these investments.
One rapidly advancing trend in healthcare and life sciences is the shift from inefficient, expensive physical models to digital models tested in the virtual world. Patient digital twins will take clinical research to a whole new level by accelerating the biotech development process at every stage to deliver tomorrow’s innovations.
Digging deeper into some of the big trends, Shelly’s observations will also ring authentic to health/care stakeholders… AI is everywhere at CES. As my friends at #JPM this week are hearing in San Francisco, AI is part of virtually every biotech and med-tech story. But it’s not necessarily useful for everything.
Here are some key trends and developments to watch: Key Trends: Technological Advancements: New technologies are revolutionizing wound care, including advanced wound dressings, bioengineered skin substitutes, and innovative wound management devices. Here are some key trends shaping the future of wound care: 1.
The company will supply solutions to AstraZeneca while extending services to pharma, biotech companies, and clinical research organizations. Operating independently within the AstraZeneca group, Evinova offers established digital technology solutions globally, aiming to optimize clinical trial design and delivery.
Anthem’s joining up with the CivicaRx program is a signal for that trend. This illustrates the tension between the cost of specialty drugs and pharma/bio innovation vis-a-vis the role of generic medicines to expand access and deliver value-based care using proven mature therapies. and beyond.
Debut Biotech : A leading cell-free biomanufacturing company that launched its own skin care product line in 2023 and raised a $20 million Series B led by L’Oreal. ” SpringTide Ventures strategically aligns its investments by engaging with industry experts and insiders to identify key trends and untapped opportunities. .
Streamlining Due Diligence with AI: AI technologies will likely be crucial in conducting efficient and thorough due diligence, examining potential M&A targets in the biotech industry for their scientific innovation, financial stability, and market compatibility. Dave Latshaw, CEO at BioPhy 1.
About SHL Medical AG As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem.
According to a Fierce Biotech report , Novo Nordisk announced in an October 31st earnings call that it is halting research and development efforts aimed at creating an oral form of insulin. to lose 1 percent of its value; and that share price were already on a recent downward trend. Trick or treat!
Every year, Hadassah provides nearly one million people with hospital services, and in keeping with worldwide trends, the Hadassah University Medical Center in Israel is moving toward day care and day hospitalization to reduce costs and risk of infection.
Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Notable Investments: Some of NVentures' significant healthcare investments include: Recursion Pharmaceuticals: A biotech company using AI to discover new drug candidates. Why Healthcare?
Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. They can view historic data and forecast future trends.
Panel Discussions and Workshops: Numerous panel discussions and workshops focusing on current trends, challenges, and opportunities in the healthcare sector. Announcements and Media Coverage: There’s extensive media coverage of the events, company news, and major industry trends. Where should I stay?
According to a Fierce Biotech report , Novo Nordisk announced in an October 31st earnings call that it is halting research and development efforts aimed at creating an oral form of insulin. to lose 1 percent of its value; and that share price were already on a recent downward trend. Trick or treat!
The biotech company is a spin-out of the University of Dundee and develops targeted protein degradation medicines, which have the potential to treat serious diseases that currently have limited treatments. This trend is likely to continue, as digital health technologies become more affordable and accessible.
In an attempt to reverse this trend and focus on other areas of the diabetes market, the company has acquired Companion Medical , the makers of InPen. The terms of the acquisition have not been released but the 2019 revenue for Companion Medical has been estimated at around $11 million, according to Fierce Biotech.
The biotech company is a spin-out of the University of Dundee and develops targeted protein degradation medicines, which have the potential to treat serious diseases that currently have limited treatments. This trend is likely to continue, as digital health technologies become more affordable and accessible.
Best Mobile Innovation for Health and BioTech c. Key Trends in Europe and Top Tips & Errors to Avoid for a Successful Outcome. This workshop will deal with key trends in fund raising and M&A for tech startups in Europe and with top tips for a successful outcome + errors to avoid. Date & Time. Monday, 25 Feb.
She has been involved with more than 20 early-stage biotech and healthcare startups, including ones working on medical devices and digital health. Remote patient monitoring is still in the first five years of adoption and integration into the healthcare system, and the pandemic accelerated this trend by illustrating the need and value of RPM.
Kristin unpacked the trend, noting three key factors underneath consumer health’s slow growth in 2018: a less severe cold and flu season, limited product innovation in 2018 (with virtually no Rx to OTC switch), and a growth of private labels outpacing more expensive brands for vitamins, sleep aids, antacids, support devices, and first aid.
The key trends that are expected to shape the market in 2023 include: Increased focus on digital health: Healthcare companies are increasingly looking to acquire digital health businesses in order to improve their offerings and stay ahead of the competition.
Each of these epidemiology studies shows the same trend: A marked survival benefit in countries who routinely use the BCG vaccine. Dr. Faustman explained that right now there are a number of biotech drugs being tested for use in severely ill patients as well as many companies pursuing a true vaccine for COVID-19.
Key trends driving strategic HealthTech acquisitions: Some of the specific trends that are driving strategic HealthTech acquisitions in today's market: The increasing demand for digital health solutions: The aging population and the growing prevalence of chronic diseases are driving the demand for digital health solutions.
It’s a volume speaking volumes on the current picture of prescribed meds, spending and revenues, health care utilization trends, and a forecast looking out to 2027. Reviewing the annual 2023 report from the IQVIA Institute for Human Data Science discussing The Use of Medicines in the U.S. health care: “Wake up, public health!”
The report is organized into four sections: medical use trends; costs and spending on meds and growth dynamics underlying the top line numbers; patient out-of-pocket costs; and that five-year forecast to 2023. prescription drug market might look like five years from now.
Thanks to Rob Jekielek, Managing Director of the Harris Poll, for sharing this graph with me for us to understand the details comparing pharma’s to other industries’ reputation trends in the past year of the pandemic. consumers trusted the biotech health industry segment compared with the pharmaceutical segment.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content